Crizotinib (877399-52-5) (C21H22Cl2FN5O)

We Are Supplier, Exporter And Contract Manufacturer.Technical Profile Of Crizotinib, A High-Purity Raw Chemical Material Supplied By Triveni Chemicals For Industrial Manufacturing And Laboratory Synthesis.

Crizotinib Is A Synthetic, Small-Molecule Tyrosine Kinase Inhibitor (Tki) Used As An Anticancer Pharmaceutical Ingredient. It Is Generally Supplied As A White To Pale Yellow Crystalline Powder And Has Limited Solubility In Water. Crizotinib Is Designed To Inhibit Specific Receptor Tyrosine Kinases, Particularly Anaplastic Lymphoma Kinase (Alk) And Ros1, Which Are Involved In Signaling Pathways That Can Promote Cancer-Cell Growth And Survival. By Blocking These Kinase Pathways, Crizotinib Can Help Inhibit The Proliferation And Progression Of Tumor Cells Carrying Specific Genetic Alterations. Its Chemical And Pharmacological Properties Make It An Important Active Pharmaceutical Ingredient (Api) For Targeted Cancer Therapy.

Crizotinib Is Primarily Used In The Pharmaceutical Industry For The Development And Manufacture Of Targeted Therapies For Certain Types Of Cancer. It Is Particularly Associated With The Treatment Of Alk-Positive Metastatic Non-Small Cell Lung Cancer (Nsclc) And Can Also Be Used For Certain Ros1-Positive Nsclc Cases, Subject To Applicable Regulatory Approvals And Prescribing Requirements. Crizotinib Is Formulated Primarily As An Oral Medicine, Allowing Systemic Delivery Of The Active Ingredient. Pharmaceutical Manufacturers And Research Organizations Use Crizotinib In Api Development, Formulation Research, Analytical Testing, And Oncology Drug Development. Because It Acts Selectively On Molecular Targets Associated With Particular Cancer Types, Crizotinib Represents An Important Ingredient In Precision Oncology And Targeted Cancer Treatment.